Novo Nordisk's Ozempic gains positive EMA opinion for label update after FLOW trial data show significant kidney and ...

They rationed their remaining supplies, stretching the weekly injections to 10 days, two weeks, even three weeks. They ...

Telehealth firm Ro has partnered with Eli Lilly And Co (NYSE:LLY) to enhance patient access to Zepbound (tirzepatide) ...

CELLEV8 Launches First Post-GLP-1 Gummy Supplement: 'SlimCell™' with Clinically Proven Ingredients to Compliment GLP-1 ...

With the Biden administration pushing for Medicare, Medicaid coverage of GLP-1s, analysts disagree on whether it will ...

But weight loss alone does not explain the drugs’ benefits. Both Holst and Sattar pointed to a discontinued GLP-1 drug once ...

A slowdown of the digestive tract (gastroparesis) can be a serious side effect, though. Researchers who analyzed the health records of 16 million people revealed that pancreatitis and bowel ...

People struggling with their body weight experienced joy when new, more effective prescription drug options became the rage ...

Randomised controlled trials and real word evidence have consistently shown that GLP-1 receptor agonists are effective and ...

A recent New York Times story described a new fad: "microdosing" GLP-1 anti-obesity drugs like semaglutide (Ozempic, Wegovy) ...

Here are 10 major orthopedic studies conducted in 2024 to know: ...

Studies suggest that semaglutide reduces heart attack and stroke and may curb addiction and more. Scientists reflect on the future of GLP-1 drugs beyond weight loss.